Search

everythinglearnresearchcommunity

for

Search:↓

UVB exposure in human skin causes macrophages to produce more IL-10 and less IL-12, leading to immunosuppression.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

Photodynamic therapy can potentially remove nonpigmented hair by damaging hair follicles.

Cetuximab often causes skin problems, but they can be managed without stopping treatment.

The document concludes that individualized treatment for malignant epithelial tumors is necessary and more research on metastatic squamous cell carcinoma treatments is needed.

miR-5110 affects alpaca pigmentation by altering specific gene expressions.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

WYE-130600 may cause skin thickening and irritation.

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.

Melanocytes are destroyed by factors needed for melanin production, causing vitiligo and gray hair.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

Topical metformin shows promise for skin treatments but needs more testing for safety and effectiveness.

Bcl-2 overexpression protects against UVB damage but worsens hair loss from chemotherapy.

Permanent makeup can cause delayed allergic reactions, but they can be managed with proper treatment.

Bone marrow and hair follicle cells help form skin tumors, suggesting new treatment targets.

Activating PPAR-γ signalling can protect hair follicle stem cells from damage caused by chemotherapy.

Melanin absorbing light is necessary but not enough for effective hair removal by light treatment.

Treating vitiligo with stem cells and melanocytes from hair, along with UVB light, works better than without the light.

Topical sensitizers have mixed success in treating alopecia areata.

Melatonin protects skin against UV damage by regulating various cellular processes.

New vitiligo treatments focus on controlling immune damage and restoring skin color.

Hydrogen peroxide is a major risk factor for melanoma in swimmers, more than UV light.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

Vitiligo is a systemic disease with psychological effects, and new treatments focus on personalized care.

CAP7.1 is generally safe at 200 mg/m²/day, but can cause fatigue, nausea, hair loss, fever, and blood-related issues.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

Mice without the vitamin D receptor are more prone to UV-induced skin tumors.

Living near more dermatologists and using certain cancer screening tests lowers the chance of being diagnosed with advanced skin cancer.